– The medical products maker hopes to leverage RWA technology to transform and leverage its current product infrastructure and budding…
Browsing: HealthCare
HONG KONG, Sep 18, 2025 – (ACN Newswire) – CGSI reiterates the “Add” rating on Modern Dental (03600.HK) with a higher…
Nadzim Johan, Chief Activist of Muslim Consumers Association of Malaysia (Persatuan Pengguna Islam Malaysia or PPIM) (L) and Rajen Manickar,…
HONG KONG, Sep 17, 2025 – (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the…
HONG KONG, Sep 15, 2025 – (ACN Newswire) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade,…
Company leverages dual-market strategy and technology-driven standardization to strengthen its leadership in China’s TCM sector and enter international markets. Sichuan…
Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored…
On August 29, Everest Medicines (HKG: 1952) announced its interim results for the six months ended June 30, 2025. The…
– Continuous Enhancement of Operational Efficiency and Productivity under Accelerated Digitalization in Dentistry RESULTS HIGHLIGHTS: – The Revenue for the…
– Implementing ‘One Horizontal, One Vertical’ Strategy – AI Empowers Medical Institution Alliances to Strengthen New Quality Productive Forces HONG…
SHANGHAI, Aug 28, 2025 – (ACN Newswire) – Hua Medicine (the “Company”, HKEx: 2552) announced the unaudited consolidated results of the…
Agreement combines advanced TPU portfolio with Formerra’s expert compliance know-how and agile service. ROMEOVILLE, IL, Aug 27, 2025 – (ACN…
– Revenue up 5.8% to HK$876.5 Million, Profit up 3.8% to HK$ 163.4 million – 16.7% Dividend Surge – Continued…
ADC pipeline with multiple products entering key clinical stages Revenue increased by 350% year-on-year Focusing on the field of tumor…
In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies,…
Australian Company Announces Landmark Paper Showing Cyclodextrin Therapy Reverses Heart Disease, Hailed as ‘Greatest Development Since Statins’ Cholrem Pty Ltd,…
Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults…
– Declares Special Dividend of HK15 Cents per Share to Celebrate 25th Anniversary – Leveraging Strategic Global Footprint and Innovative…
Everest Medicines (HKG: 1952.HK, Everest) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New…
Essex Bio-Technology Limited (Essex or the Group, HKG: 1061) is pleased to announce that a Biologics License Application (BLA) for…